JS
Joao MD Siffert
President and CEODirector

Joao MD Siffert insider trades: Design Therapeutics (DSGN) stock buys and sales

President and CEO, Design Therapeutics Last trade Dec 20, 2022 21 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
7
Open-market trades
since 2012
4
Companies
last trade 2022

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Joao reports to the SEC

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 20, 2022DSGN↑ Buy$63K
Dec 18, 2014AVNR↓ Sell$262K
Oct 24, 2014AVNR↓ Sell$99K
May 28, 2014AVNR↓ Sell$70K
Dec 18, 2013AVNR↓ Sell$16K
Sep 18, 2013AVNR↓ Sell$89K
May 10, 2012AVNR↑ Buy$8K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Joao MD Siffert's insider trades

Joao MD Siffert is President and CEO at Design Therapeutics (DSGN). Since May 10, 2012, Joao has reported 2 open-market purchases worth $70K and 5 sales worth $537K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (13 filings), option exercises (3 filings), shares returned to the company (1 filing), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DSGN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.